Zydus Cadila gets tentative USFDA nod to market anti-cancer drug

Palbociclib is an anti-cancer medicine. Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer drug Palbociclib Capsules. Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Palbociclib Capsules in the strengths of …

Read moreZydus Cadila gets tentative USFDA nod to market anti-cancer drug